Introduction 31
Community and patient level control measures of Tuberculosis (TB) currently rely on clinical 32 surrogates of infectivity. These include presence and frequency of cough, extent of cavitatory 33 disease on chest radiograph (CXR), sputum smear acid-fast bacillary (AFB) or Xpert MTB/RIF grade 34 and bacterial burden in culture 1 . 35 These indicators are chosen on the basis that they reliably inform the risk of onward transmission of 36 the infection by patient generated aerosols from those individuals with marked pulmonary disease. 37 However, the overall contribution of this patient group to transmission across populations is 38 uncertain. It would clearly be desirable to replace these indirect markers of infectivity with direct 39 assessment of patient generated aerosols, both in specific cases assessment and in broader 40 programmes of active case finding. 41
Evidence for the airborne transmission of TB was first presented by Riley and colleagues (ref) using a 42 guinea pig model, where animals are exposed to the room air from pulmonary TB patients. Recently, 43 Fennelly and colleagues have captured culturable infectious aerosols containing Mycobacterium 44 tuberculosis (Mtb) directly from patients using the Cough Aerosol Sampling System (CASS) 2 . While 45 the Riley model has not been directly related to community level transmission by individuals, CASS 46 based studies have provided early reports in this regard and analyses have shown aerosol is superior to sputum smear grade as a measure of transmission risk 3 . Neither of these approaches examine the 48 characteristics of aerosol production by individuals over time. Infectivity measured by the guinea pig 49 model is not time resolved beyond cumulative exposure and CASS is based on a single episode of 50 forced coughing that may not reflect natural aerosol production. 51
We have previously reported on a novel Mask Aerosol Sampling System (MASS) that captures Mtb 52 directly from patients under natural conditions 4 , offering the possibility for studying this important 53 question. 54
In this prospective study, we have utilised MASS to investigate the dynamic patterns of Mtb output, 55
including possible diurnal variation, in patient-generated aerosols over 24 hours. We compare this 56 with Mtb in expectorated sputum over the same period and investigate the association of these 57 direct measures of infectivity with conventional measures of transmission risk commonly used in 58 clinical practice. Our key hypotheses are that sputum bacillary content, cough frequency and extent 59 disease on CXR are associated with Mtb detected in mask samples. 60
Methods 61

Study Population 62
Hospitalised pulmonary TB patients diagnosed by either Xpert MTB/RIF or smear AFB positive on a 63 sputum sample were invited to take part at three hospital sites in Pretoria, South Africa (Steve Biko 64 Academic Hospital, Tshwane District Hospital or Kalafong District Hospital) between September and 65 December 2015. Participants were eligible if they were 18 years or older, did not require continuous 66 oxygen therapy by face mask or nasal prongs and were untreated or within 24 hours of starting anti-67 TB treatment. 68
Ethical consideration
Patients were consented in their preferred language and provided written consent. This study was 70 approved by the Faculty of Health Sciences Research Ethics Committee at the University of Pretoria 71
and Provincial approval from Gauteng Health Department (ref: RET_215_UP03). 72
Aerosol and Sputum Sampling 73
Each participant wore a modified FPP1 face mask containing a gelatine filter (pore size 0.3µm, 74 Sartorius, Germany). They were given no set instructions on vocal manoeuvres during this time and 75 allowed to cough, talk, laugh or sleep as desired. If they needed to expectorate then they were 76 asked to lift the mask briefly, after coughing, to expectorate into a sputum collection pot. 77
Each participant underwent MASS for an hour every three hours and were provided with a new 78 sputum pot at every three hour interval and encouraged to collect whatever they expectorated 79 spontaneously for the 24 hour study duration. 80
They were observed to ensure that the mask was worn for the whole hour of sampling and 81 participant behaviour was recorded, including anytime the mask was directly in front of the mouth. 82
Sleep was documented if the participant had their eyes closed for >10 minutes and were not 83 obviously rousable by noise, resting was noted if the participant had their eyes closed for <10 84 minutes at a time and/ or had their eyes open but not engaging in any activity such as talking, eating, 85 reading etc. Other activities such as eating, washing, reading and talking were documented. 86
To provide background controls swabs were taken from a total of 72/192 masks, holders and 87 transport bags to address the possibility of environmental contamination under the same conditions 88 as the processed masks. All were negative by PCR. 89
Initial processing of Aerosol and Sputum samples 90
Gelatine filters were dissolved in 1.5mls of 2% w/v NaOH and incubated at room temperature for 15 91 minutes before neutralising with 190μl 4M HCL. Samples were agitated by hand at 0 and 8 minutes. 92
The dissolved filter was then centrifuged at 13,400 xg for 10 minutes, the supernatant removed and 93 the pellet overlaid with 100μl of TE buffer (20mM Tris and 2mM EDTA pH 8.0), prior to storage at -94
80°C. 95
As in our previous work 4 , we have assigned bacillary output recovered from this mask sample to be 96 in aerosols, although we acknowledge that a range of particles including those outside the respirable 97 range are likely included. We have used the terms mask and aerosol sampling interchangeably to 98 denote results from this sample. 99
Sputum was decontaminated and processed in accordance with Turapov and colleagues 5 , before 100 being re-suspended in 1ml of the supernatant, passaged through a 23G blunt needle 10 times and 101 centrifuged at 13,400xg for 10 minutes. The supernatant was removed and the pellet overlaid with 102 100μl of TE buffer (20mM Tris and 2mM EDTA pH 8.0) prior to storing at -80°C. 103
Extraction and quantification of DNA from bacterial pellets 104 Bacterial pellets from the aerosol and sputum samples underwent the same in-house extraction 105 method modified from that outlined by Reddy and colleagues 6 . 100μl Chelex-NP40 (50% w/v Chelex-106 100, 1% w/v Non-idet P40, 1% w/v Tween 20) was added to the defrosted bacterial pellet along with 107 0.3g glass beads (150-212μm Sigma-Aldrich USA). The sample was then homogenised in a Fast Prep 108 at 6.5 m/s for 45 seconds and ice incubated for 5 minutes. This homogenisation step was repeated 3 109 further times prior centrifugation at 13,400xg for 2 minutes. 200μl of the supernatant was heated at 110 95°C for 30 minutes prior to removal from the CL3. 111
Copy numbers of IS6110 were quantified in each sample by real-time q-PCR run on a Rotor-Gene 112 (Qiagen UK) using a TaqMan IS6110 assay outlined by Akkerman and colleagues 7 . Real-time PCR 113 signals were analysed by Rotor-Gene 6000 Series Software 1. The functions "slope correct" and 114 "ignore cycles" were applied to analyses. In accordance with Dorak and colleagues only runs with 115 correlation coefficients (R 2 ) and reaction efficiencies above 0.99 and 0.8 respectively were included 116 for analysis 8 . Technical replicates were undertaken in triplicate and considered reproducible if the 117 difference in cycle threshold (Ct) was less than 1. 118
As differences in IS6110 copy number between bacterial strains limits confidence in comparative 119 analysis, a subset of samples for each participant was further analysed using the Mtb-specific RD9 120 DNA sequence, single copy gene 9 . Comparative statistical analyses have been assessed using both 121 IS6110 copy numbers and genome copy number derived using the ratio between IS6110 and RD9 122 (see supplemental data). 123
Cough Sampling 124
A Leicester Cough Monitor (LCM) was worn by each participant for the 24 hours of the study. As 125 described by Birring and colleagues, the LCM consists of an MP3 recorder (Sony ICD PX333) worn at 126 the participant's waist in protective bag connected to a clip microphone (Philips LFH9165) that is 127 worn as close to the sternoclavicular joint as possible 10 . Recordings are analysed using specialised 128 semi-automated software as previously described, that anonymised sounds and quantified coughs 129 both as single events or cough bouts 10 . The LCM position was checked every 3 hours throughout the 130 study. As well as being well validated for use in patients with many respiratory conditions including 131 TB 10-13 the LCM was validated for use with MASS prior to this study. 132 A subset of the recordings were validated by a second member of the research team, who was 133 'blinded' to the patient information and the primary analysis of the recording. There was good 134 agreement in the subset reviewed by both members of the research team with an Intra-Class 135 Correlation of R=0.99 (CI 0.996-1.00). 136
Nocturnal and daytime cough were defined by the time periods of 23:00-05:00 and 05:00-23:00, 137 respectively. These periods were determined by observations of both the participants and working 138 patterns of the hospital ward. 139
Participant Data Collection 140
Clinical and demographic data was collected for each participant including routine microbiological 141 investigations; sputum AFB smear microscopy, Xpert MTB/RIF and liquid culture (BACTEC MGIT 960). 142
Radiological changes were graded using methods described by Ralph 
Results 155
We first established the quantitative features of our sampling system in vitro. Direct contamination 156 of mask filters with Mtb dilutions of mid-exponential culture, revealed a limit of detection of 152 157 colony forming units. We further determined that exposure to aerosols of M. bovis BCG for 15 158 minutes confirmed the capacity of the system to detect a suitable dynamic range. (see supplemental 159 data) 160
Patient enrolment and clinical characteristics 161
Of 78 pulmonary TB patients screened in Pretoria, South Africa, 33 patients were ineligible and 20 162 declined participation either prior to or after study enrolment (Figure 1). One further patient was 163 excluded from analysis after sputum sampling identified M. intracellulare infection (figure 1). For 16 of the 24 participants completing the study, all samples were taken prior to commencing TB 165 treatment, with the other 8 receiving a single dose either prior to or during their respective sampling 166 periods (Table 1) . 167
All study participants were Black African and hospitalised with microbiologically confirmed advanced 168 pulmonary TB (Table 1 ). The median age of the cohort was 35 years and 14 participants (58%) were 169 female. HIV co-infection was identified in 20 participants (83%), with a median CD4 + cell count of 35 170 cells/ml, of whom 4 (20%) were receiving antiretroviral therapy at enrolment. 171
Four patterns of aerosol production were observed 172
A one hour mask sample was readily obtained from all 24 participants during each of 192, three hour 173 sampling periods. As evident in Figure 2 minimum detected hourly output, whilst the majority showed variation below 5 fold (see 178 supplemental data); the remaining 6 participants produced several samples exceeding this limit. On 179 this basis we determined four patterns of aerosol production, with respect to Mtb detection, in our 180 cohort: i. Negative aerosol producers; ii. Consistent aerosol producers; iii. Low variable aerosol 181 producers and iv. High variable aerosol producers (fig 2) . These patterns were not influenced by the 182 diurnal cycle. 183
Aerosol samples were taken at 68 time points when participants were observed to be sleeping for 184 the full one hour sampling from 23/24 participants (with the exception of a brief rousing to place the 185 mask on and off). Mtb was detected in 53 samples from 19 participants. The median (IQR) Mtb 186 burden detected during sleeping was 1.4x10 4 (5.0 x10 3 -2.6x10 4 ). In contrast, cough frequency was significantly lower during these sampling periods (median (IQR) 4 (1-17)). It was particularly striking 188 that for 11 of these aerosol samples Mtb was detected with no occurrence of cough (fig 4) . 189
Conventional markers of infectivity do not associate with aerosol production 190
Sputum was spontaneously produced by 18 of our 24 (75%) participants at 51 of a possible 192 191 (26.5%) time points with 1 to 8 samples produced and total volumes between 1 and 185 ml (Fig 2) . 192
Eight sputum samples from three patients were excluded due to processing errors. There was no 193 observable diurnal pattern in either sputum production or Mtb content per sputum sample (Fig 3) . 194
While 24 hour Mtb sputum content was significantly higher than that in aerosol (p=0.02), in four 195 participants the converse relationship was apparent ( fig 2) . We found no association between 196 sputum and aerosol Mtb production either over the whole over 24 hours (p=0.06) or within the four 197 Of the 33 aerosol samples that were negative for Mtb taken from 7 participants, 30 had coughs 208 detected during sampling. The median cough frequency for these aerosol negative samples was 8 (2-209 37) which is similar to that demonstrated by the whole cohort (10 (2-22)). The discordance between 210 cough frequency and MTb aerosol production was most evident in the 6 samples that recorded more 211 than 50 coughs/hour ( range 54-318). 212
Neither extent of disease nor presence of cavities on CXR were associated with total aerosol Mtb 213 production (p=0.52). Sputum samples used in assessing participant eligibility, taken 24 hours prior to 214 study commencement yielded AFB and Xpert grade as well as MGIT days to positivity, none of which 215 showed correlated with 24 hour Mtb aerosol production. This can be seen in table 2 alongside other 216 standard patient associated features (also not associated) and is equally true for the repeated 217 analysis using RD9 normalised Mtb signals in aerosol and sputum. 218
Previous studies report associations between cough and AFB grade, extent of disease on CXR and 219 days to culture positivity in liquid culture and this was confirmed in our cohort. Like Turner et al (ref) 220 we did not find that cavitations and cough were correlated (p=0.88). (see supplemental table) . 221
Consistent with previous studies daytime cough frequency was higher than night time (p=0.04), 222 women had a higher cough frequency than men (p=0.04) and cough frequency correlated with 223 participants' reported cough using a visual analogue scale (VAS) (ρ=0.50 (0.09 -0.80) p=0.02). 224
Potential Implications for TB Diagnosis 225
Mtb was detected by mask sampling at 166/192 (86.5%) possible sampling time points. In contrast, 226
Mtb was detected from sputum in 38 of the 184 assessable (20.7%) sampling time points. 227
In the 43 sampling periods for which concomitant sputum and aerosol were available Mtb was 228 detected by either aerosol or sputum in all sampling periods. However, there was discordance 229 between the sampling methods for 12 of these periods. For 7 of these periods, sputum was Mtb 230 positive and aerosol negative, while in the other 5 periods, aerosol identified Mtb but sputum was 231 negative. 232
Discussion
Using adapted face masks, we have been able to gain insight into the daily Mtb output in patient-234 generated aerosols. In contrast to established sampling methods, the MASS is simple, well tolerated 235 and compatible with routine clinical practice. We have also presented evidence that conventionally 236 applied indicators of individual infectivity do not predict aerosol output and that the MASS approach 237 may have value as a broadly applicable non-invasive tool for both diagnosis and informing the likely 238 infectivity of the active case. This study raises questions regarding current strategies widely used to 239 assess patient infectivity. 240
While the work of Riley and Wells made it clear that aerosols were critical to transmission in guinea 241 pig facilities 15-17 , only the work of Jones-Lopez and colleagues using the CASS has linked individual 242 aerosol output levels with community transmission 3 . The work presented here, establishes the value 243 of the MASS to recognise differences in aerosol production between and within individuals but not 244 its link to transmission. It would none the less be surprising if the quantity of Mtb aerosols captured 245 in MASS was not associated with transmission. 246
Four patterns of aerosol production were observed and no diurnal pattern was evident 247 TB transmission is likely dependent on the number and quality of mycobacteria expelled into 248 aerosol, however, until this study there has been no direct information on the pattern with which 249 this occurs spontaneously. We identified four distinct groups of aerosol Mtb production over 24 250 hours. We were unable to find any features of their clinical presentation, particularly CXR that would 251 explain these differences. 252
We found no evidence of a diurnal pattern in aerosol Mtb production. While this might reflect a bias 253 of hospitalisation disrupting natural diurnal rhythm, a diurnal pattern of cough pattern was 254 observed that is concordant with other studies 10, 11, 13 . It is also interesting that 53 positive aerosol 255 samples were collected from participants that were directly observed to be sleeping for the full hour 256 of sampling.
Aerosol Production was not associated with traditional markers of infectivity 258
In the 43 sampling periods where both sputum and aerosol were available, Mtb content within these 259 samples were not correlated. Moreover, the 24 hour output of bacilli in sputum did not predict that 260 detected in aerosol and we conclude for individuals within this cohort, sputum content could not be 261 used to predict aerosol output. This was also the case for Sputum AFB and Xpert MTB/RIF grade 262 along with time to positivity in liquid culture. Recent data from Patterson and colleagues shows a 263 similar discordance between sputum and aerosol production by participants in a South African 264 setting 18 . 265
We observed no significant relationship between cough frequency and aerosolised Mtb production 266 either for the full 24 hours of the study or at each individual time point assessed. In the Patterson 267 study spontaneous cough frequency correlated with culturable bio-aerosol production detected in a 268 specially designed cabinet 18 . Using the CASS approach, where patients were invited to cough, 269
Fennelly and colleagues noted a trend associating cough frequency with colony forming units 2 and 270 more recently they reported an association with cough strength 3 . These groups, like us, failed to find 271 any association between extent of disease and presence of cavitation on CXR with aerosol output. 272
The reason for some of difference in results concerning cough may reflect the difference in sampling 273 methods. The CASS and cough cabinet used by these groups selectively capture Mtb remotely from 274 either a drum or large cabinet, in which the particles have time to desiccate into the respirable 275 range. MASS, on the other hand, is non-selectively sampling both aerosols and droplets in a more 276 proximal position. 277
Relevance to Transmission 278
Comparing MASS with the CASS we note that output in the former reflects spontaneous 279 expectoration over an hour whilst the later, a short 10 minute directed voluntary cough sample. It 280 should also be appreciated that CASS captures colony forming bacilli assignable within the respirable range by use of the Andersen sampling system 2,3,19 . Through multiple sampling it has been possible 282 to readily assess the consistency of output in our subjects, while no similar data is currently available 283 for CASS. 284
It is striking that two highly variable aerosol producers were distinct in their 24 hour output from 285 others in this HIV dominated group by more than an order of magnitude. This frequency concurs 286 remarkably well with the findings of Escombe and colleagues in that 8.5% of an exclusively HIV 287 cohort were highly infectious 20 . In considering how the patterns we have observed may relate to 288 recognised individual events, we suggest that transmission from highly variable producers maybe 289 associated with infection acquired from transient contact as a stochastic event, while that from the 290 consistent producers may explain the utility of cumulative exposure time to inform linear risk in 291 household and other close contacts. The relative importance of these two distinct mechanisms to 292 transmission within populations remains uncertain. 293
In considering the relevance of sputum smear positivity to transmission, a recent meta-analysis, 294 based on 37 studies, gave an adjusted odds ratio of 2.15 (1.47-3.17) 1 . Such population level studies 295 contrast with a key CASS finding demonstrating a strong association (greater than 5 fold) between 296 aerosol bacillary burden and transmission, while no such significant association was observed with 297 sputum AFB grade. These authors also noted that 'although aerosol production was correlated with 298 sputum AFB smear grade in this and our previous studies, most subjects with high-grade smear (i.e 299 AFB ≥3+) where aerosol negative' 3 . These findings accord with the dissociation between the aerosol 300 and sputum results recorded here. 301
Considering reported cough, in several studies, various levels of association with transmission have 302 been reported 1, 3, 12, 18, 21 . In the two studies where cough was independently assessed, a modest 303 association with transmission was reported. Turner and colleagues using 24 hour data from the 304 Leicester Cough Monitor, found an odds ratio of 1.30 (1.04-1.64) 12 while Loudon and Spohn assessed 305 night time cough counts and showed a trend to association with transmission (p=<0.20) 21 . In the latter regard, it is striking that we detected positive aerosols in 6 sleeping individuals where no 307 cough was recorded on 11 separate occasions. It is also interesting that there were 6 occasions with 308 high cough frequency (>5x the median cough frequency for the whole cohort) and no aerosolised 309 Mtb detected. Although this could suggest a difference in our study population, in every other 310 respect cough was predicted by the same patient indices (sputum and CXR grade) as the previous 311 studies 12, 18, 21, 22 . 312
The meta-analysis of Melsew and colleagues report and adjusted odds ratio of 1.90 (1.26-2.84) for 313 the relationship between caviatory lung disease and transmission 1 . As reported by Jones-Lopez et 314 al 3 , we found no association between aerosol Mtb production and extent of disease or the presence 315 of cavitations on CXR. 316
Traditional indices of sputum grade, cough frequency and CXR changes are widely applied in clinical 317 and public health practice to assess infectivity at the individual level. It is therefore surprising that 318 neither our study, nor the CASS studies, show an association between these factors and Mtb aerosol 319 production. Given the strength of association of aerosol Mtb production with household 320 transmission found by Jones-Lopez et al 3 we consider, at the very least, the need to develop and 321 adopt additional tools to support risk assessment for transmission. 322
Potential diagnostic Implications 323
Although it was not our original aim to determine the diagnostic value of MASS, we find it notable 324 that aerosol samples were successfully obtained in every sampling period from every individual 325 while this was only the case for sputum in less than one third of occasions. Given that Mtb was 326 detected in 86.5% of aerosol samples and 88.4% of sputum samples, we suggest that aerosol 327 sampling may offer a comparable result more frequently. Considering the ways in which mask 328 sampling could be incorporated into clinical practice we note that this would be particularly 329 advantageous in those patients that do not produce sputum or are smear negative at the first clinical 330 encounter. Incorporating this approach into the primary diagnostic pathway could contribute to 331 identifying the 'missing millions' identified by the WHO 23 . 332
Limitations 333
To our knowledge this is the first observational study in which spontaneous output of Mtb in sputum 334 and aerosol has been assessed over 24 hours. 335
The general applicability of our findings must be reviewed with caution. Firstly, the continuous 336 monitoring of patients in this study required selection of hospitalised patients; this meant our 337 participants tended to have more complicated or advanced disease. Secondly, the rate of HIV-TB co-338 infection in our cohort was higher than the WHO's estimated rate of 57% in South Africa in 2015 24 . 339
Thirdly, by restricting our eligibility criteria to sputum AFB/Xpert MTB/RIF positivity, our results may 340 not apply to TB patients who are sputum negative or unproductive of sputum. Finally the small 341 sample size of this study may have influenced our findings and made drawing conclusions about 342 predictors of aerosol production within the groups difficult. That said, our findings do provide 343 synergy with other groups with respect to some aspects of sputum bacillary load, cough and chest 344 xray findings allow some confidence in its generalisability. 345
The choice of IS6110 as a multi-copy gene target, whilst providing sensitivity, complicates 346 comparisons between patients within our cohort. Our normalisation to RD9 gives us some 347 confidence in the comparisons we can draw. Two samples analysed for RD9 and IS6110 were RD9 348 negative but IS6110 positive supporting the choice of IS6110 for the majority of the analysis. We 349 cannot say what proportion of the signals detected here represent potentially infective bacteria as 350 our PCR would have detected DNA from both alive and dead bacteria. We note that signals from 351 viable bacteria comparable to those detected here, were reported in our previous study 4 . Moreover, 352 the culturable signals noted above in association with cough 2,3,19 would not have detected in the 353 bacterial that are incapable of forming colonies on solid media and require liquid culture and 354 supplementation for their growth 25 . Although our group has previously demonstrated high numbers 355
of Mtb with these requirements in sputum 25 , their occurrence in aerosol is has yet to be determined. 356
Conclusion 357
We conclude that our primary hypothesis that traditional markers of infectivity should determine 358 aerosol production, is not supported by our findings. Whether this reflects weakness in these 359 markers or deficiencies in aspects of our study design will require further investigation. 360
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Comparison of RD9 and IS6110 signals in subset of samples for Participants with calculated ratios
Limit of Detection Methods
Mid -exponential Mtb H37Rv underwent serial 10-fold dilution to 10 7 and filters were contaminated with 100μl of each dilution in 10µl drops across the surface of the filter. Mycobacterial DNA was isolated and extracted before IS6110 copies were quantified. A negative control arm was analysed using un-contaminated filters. This experiment was conducted in technical triplicate. The CFU of original Mtb suspension was calculated using the drop plate method described by Hoben and colleagues 1 . The number of Mtb genomes recovered was calculated by dividing the absolute quantification of IS6110 by 16 (IS6110 copy number in H37Rv).
A limit of detection (LoD) for this method was calculated using the following formulae outlined by Armbruster and colleagues 2 , the results from the dilution series and a further 9 blank filters which were processed in the same way in order to calculate the limit of the blank (LoB). LoB = meanBlank + 1.645(SDBlank) LoD = LoB + 1.645(SDlow concentration sample).
Variation of PCR signals within consistent aerosol producers.
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